Search in the Abstract Database

Search Abstracts 2011

* = Presenting author

Poster presentations: Clinical Diagnosis and outcome (2011)

P052. Fecal calprotectin is reliable surrogate marker of endoscopic and histologic mucosal healing in Crohn's disease and ulcerative colitis

P053. Is there a change in the natural history of Crohn's disease; Surgical rates and medical management in a population-based inception cohort from Western Hungary between 1977–2008

P054. Serial tuberculin skin tests to detect latent tuberculosis in inflammatory bowel disease patients receiving infliximab therapy

P055. A population-based study: do women with Crohn's disease breastfeed?

P056. Pulmonary function tests in patients with ulcerative colitis

P057. Clinical course of concurrence of inflammatory bowel disease and multiple sclerosis: Results of a national multicentre study [GETAID Group]

P058. Beyond the ordinary diagnostic study: The “real life” accuracy of faecal calprotectin for screening children with suspected inflammatory bowel disease

P059. Development of patient reported outcome (PRO) instruments in ulcerative colitis and Crohn's disease

P060. Does the development of primary sclerosing cholangitis in IBD require the presence of colonic inflammation?

P061. IFN-γ release assay in screening for latent tuberculosis in inflammatory bowel diseases

P062. Serum cytokine profile is related with disease activity in ulcerative colitis patients

P063. Disease extension is the major factor affecting the disease course of ulcerative colitis (UC)

P064. Magnetic resonance enterography for Crohn's disease: Surgical aspects

P065. A tertiary centre experience of vulval Crohn's disease

P066. Diagnostic tests for CMV colitis in inflammatory bowel diseases

P067. Comparison of wireless capsule endoscopy and enteroclysis in the work-out of patients with established and suspected small bowel Crohn's disease

P068. Factors associated with the development of rheumatologic manifestations in patients with ulcerative colitis

P069. Identification of subgroups of adalimumab-treated patients with Crohn's disease who experience high rates of deep remission

P070. Economic impact of deep remission in adalimumab-treated patients with Crohn's disease: Results from EXTEND

P071. Are isolated ileal abnormalities a clinically relevant entity? A retrospective study

P072. Diagnostic medical radiation in inflammatory bowel disease: Primum non-nocere?

P073. A comparative study of clinical, endoscopic and histologic findings in patients with gastrointestinal Behçet's disease and Crohn's disease

P074. Impact of smoking on Crohn's disease clinical course: Data from the multicenter Spanish study “TABACROHN”

P075. Can clinical parameters of disease severity help to predict risk for osteoporosis in inflammatory bowel disease?

P076. Magnetic resonance enterography in adolescents and young adults with Crohn's disease

P077. Diagnostic utility of anti-Saccharomyces cerevisiae antibody (ASCA) and interferon-gamma assay in the differential diagnosis of Crohn's disease and intestinal tuberculosis

P078. The first experience in marked mesenchymal stromal cell in Crohn's disease

P079. Level changes of serum anti-glycan antibodies in individual Crohn's disease patients over time

P080. Current European practice in diagnosis and treatment of IBD-associated anaemia

P081. Post surgical recurrence in patients with Crohn's disease: Accuracy of abdominal ultrasonography with oral contrast enhancement performed six months after surgery

P082. Diagnostic accuracy of confocal fluorescence microscopy in diagnosing dysplasia in patients affected by long-standing ulcerative colitis

P083. Risk factors and impact of Clostridium difficile infection in acute severe colitis needing hospitalization

P084. The prevalence and efficacy of ganciclovir on steroid-refractory ulcerative colitis with cytomegalovirus infection: A prospective multicenter study

P085. Serum hepcidin and prohepcidin concentrations in inflammatory bowel disease

P086. Clinical utility of anti-glycan antibodies in pediatric Crohn's disease in comparison with an adult cohort

P087. Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease

P088. The comparison of three types of capsule endoscopes by small bowel transit time in patients with Crohn's disease

P089. Large burden of disease in early CD-patients in the Biocrohn Registry in Germany

P090. Prospective controlled analysis of vitamin B12 and folate deficiency in Crohn's disease

P091. Longstanding ulcerative colitis related dysplasia – COX-2 and ultrastructural correlations

P092. Usefulness of faecal calprotectin to detect postoperative endoscopic recurrence in Crohn's disease

P093. Impact of magnetic resonance enterography in the management of small bowel Crohn's disease

P094. Adherence with 5-aminosalicylic acid therapy: Results from a large UK pharmacy database

P095. Disaccharidases activity in children with inflammatory bowel disease

P096. Interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD in tube) versus tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease

P097. Interferon-gamma release assay or tuberculin skin test in inflammatory bowel disease patients – which is reliable

P098. Serum myeloperoxidase level is a marker of disease activity in patients with inflammatory bowel disease

P099. Systemic AA amyloidosis associated with inflammatory bowel disease

P100. Characteristics of ulcerative colitis associated with autoimmune pancreatitis

P101. Proctocolectomy and ileal pouch anal anastomosis (IPAA) significantly impairs fertility and pregnancy outcomes in ulcerative colitis (UC) patients

P102. Short and long term clinical outcome of infliximab in fulminant ulcerative colitis

P103. Using of confocal endomicroscopy in inflammatory bowel disease of children

P104. Anti-Saccharomyces cerevisiae antibodies in Crohn's disease: Role in disease stratification

P105. The individual economic impact of inflammatory bowel disease; The colonic recession

P106. Faecal calprotectin: Useful for clinical differentiation of microscopic colitis and irritable bowel syndrome?

P107. A budget impact model to evaluate medication persistence and associated healthcare costs

P108. Fistulizing pattern is associated with a higher frequency and incidence of cancer in Crohn's disease: A single-center cohort study involving 1288 patients with inflammatory bowel disease

P109. Diagnostic value of magnetic resonance enterography compared with capsule endoscopy in small-bowel mucosal lesions in patients with suspected or established non-obstructive Crohn's disease: A meta-analysis

P110. Validation of a fast genotyping method for analysis of TPMT polymorphisms

P111. Arterial stiffness in patients with inflammatory bowel diseases

P112. Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn's disease

P113. Factors affecting Swedish patients' refill adherence and persistence to adalimumab therapy

P114. The diagnostic role of ASCA, Omp-C and atypical pANCA in Indian Asian patients with inflammatory bowel disease

P115. Diastolic dysfunction and its relation with insulin resistance in patients with inflammatory bowel disease

P116. Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: A population-based study from Western Hungary, 1977–2008

P117. Evaluation of stress in inflammatory bowel disease patients

P118. Previous misdiagnosis and diagnostic delay in inflammatory bowel diseases

P119. Bone mineral density in Portuguese patients with Crohn's disease

P120. Magnetic resonance enterography (MRE) in children with Crohn's disease: Results from the Belgian Pediatric Crohn's Registry (Belcro)

P121. Inter-observer agreement for Crohn's disease sub-phenotypes using the Montreal Classification: How good are we? A multi-centre Australasian study

P122. Extraintestinal manifestations in a single centre cohort of chronic inflammatory bowel disease patients

P123. Accuracy of endoscopic capsule in Crohn's disease diagnosis in an experienced unit

P124. Frequency of opportunistic virus infections in patients with inflammatory bowel diseases in Moscow region

P125. Prevalence of metabolic syndrome in a Turkish population with inflammatory bowel disease

P126. Relationship between cytokine profile and local immunity in ulcerative colitis

P127. Diagnosis of latent tuberculosis in patients with inflammatory bowel disease: Prospective comparison between tuberculin skin test and IGRA test QuantiFERON TB-Gold^®

P128. Serum IL8 concentration improves clinical activity index in ulcerative colitis

P129. Evaluation of fecal calprotectin level in patients with chronic inflammatory bowel diseases

P130. Correlation between serological biomarkers and clinical activity in patients with inflammatory bowel disease (IBD)

P131. The lack of CRP response in patients with non-colonic active Crohn's disease

P132. Thromboembolic complications in inflammatory bowel disease patients: Prevalence in a tertiary referral center

P133. K-ras, Cox-2 and membrane β-catenin positivity are characteristics of tumor-free mucosa in patients with ulcerative colitis-associated colorectal cancer

P134. A change in the attention to patients with inflammatory bowel disease: An integrated care unit

P135. 8-year experience of enterocutaneous fistulae at a national intestinal failure centre